Mirna is a clinical-stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics and is the first to establish clinical proof-of-concept for a microRNA replacement therapy for cancer.
Site
Badges
MIRNA Therapeutics, Inc.
2150 Woodward Street
Austin, TX, 78744
United States
Get started
To request access, simply fill out the form below and we will contact you.